Global Chronic Pain Treatment Market Insights, Forecast to 2025


Report ID : RC-5479 Category : Healthcare
Published Date : January 2019 Pages : 111 Format : PDF
This report mainly studies Chronic Pain Treatment market. The market growth is primarily driven by the rising prevalence of chronic conditions, surging geriatric population, and increasing government support toward chronic pain management.
During the forecast period, the chronic pain treatment market is expected to witness the fastest growth in the APAC region.

The global Chronic Pain Treatment market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Chronic Pain Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Chronic Pain Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chronic Pain Treatment in these regions.

This research report categorizes the global Chronic Pain Treatment market by top players/brands, region, type and end user. This report also studies the global Chronic Pain Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

    Eli Lilly and Company

    GlaxoSmithKline

    Pfizer

    Medtronic

    Abbott Laboratories

    Boston Scientific Corporation

    Novartis AG

    Johnson & Johnson

    AstraZeneca PLC

    Bristol-Myers Squibb

    Becton, Dickinson and Company

    Sanofi

Market size by Product

    Drugs

    Devices

Market size by End User

    Hospitals

    Clinics

    Nursing Homes

    Research Centers & Universities

Market size by Region

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

The study objectives of this report are:

    To study and analyze the global Chronic Pain Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Chronic Pain Treatment market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Chronic Pain Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

    To project the value and sales volume of Chronic Pain Treatment submarkets, with respect to key regions.

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Chronic Pain Treatment are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chronic Pain Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage

    1.1 Chronic Pain Treatment Product

    1.2 Market Segments

    1.3 Key Manufacturers Covered

    1.4 Market by Type

        1.4.1 Global Chronic Pain Treatment Market Size Growth Rate by Product

        1.4.2 Drugs

        1.4.3 Devices

    1.5 Market by End User

        1.5.1 Global Chronic Pain Treatment Market Size Growth Rate by End User

        1.5.2 Hospitals

        1.5.3 Clinics

        1.5.4 Nursing Homes

        1.5.5 Research Centers & Universities

    1.6 Study Objectives

    1.7 Years Considered

2 Executive Summary

    2.1 Global Chronic Pain Treatment Market Size

        2.1.1 Global Chronic Pain Treatment Revenue 2013-2025

        2.1.2 Global Chronic Pain Treatment Sales 2013-2025

    2.2 Chronic Pain Treatment Growth Rate by Regions

        2.2.1 Global Chronic Pain Treatment Sales by Regions

        2.2.2 Global Chronic Pain Treatment Revenue by Regions

3 Breakdown Data by Manufacturers

    3.1 Chronic Pain Treatment Sales by Manufacturers

        3.1.1 Chronic Pain Treatment Sales by Manufacturers

        3.1.2 Chronic Pain Treatment Sales Market Share by Manufacturers

        3.1.3 Global Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)

    3.2 Chronic Pain Treatment Revenue by Manufacturers

        3.2.1 Chronic Pain Treatment Revenue by Manufacturers (2013-2018)

        3.2.2 Chronic Pain Treatment Revenue Share by Manufacturers (2013-2018)

    3.3 Chronic Pain Treatment Price by Manufacturers

    3.4 Chronic Pain Treatment Manufacturing Base Distribution, Product Types

        3.4.1 Chronic Pain Treatment Manufacturers Manufacturing Base Distribution, Headquarters

        3.4.2 Manufacturers Chronic Pain Treatment Product Type

        3.4.3 Date of International Manufacturers Enter into Chronic Pain Treatment Market

    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

    4.1 Global Chronic Pain Treatment Sales by Product

    4.2 Global Chronic Pain Treatment Revenue by Product

    4.3 Chronic Pain Treatment Price by Product

5 Breakdown Data by End User

    5.1 Overview

    5.2 Global Chronic Pain Treatment Breakdown Data by End User

6 North America

    6.1 North America Chronic Pain Treatment by Countries

        6.1.1 North America Chronic Pain Treatment Sales by Countries

        6.1.2 North America Chronic Pain Treatment Revenue by Countries

        6.1.3 United States

        6.1.4 Canada

        6.1.5 Mexico

    6.2 North America Chronic Pain Treatment by Product

    6.3 North America Chronic Pain Treatment by End User

7 Europe

    7.1 Europe Chronic Pain Treatment by Countries

        7.1.1 Europe Chronic Pain Treatment Sales by Countries

        7.1.2 Europe Chronic Pain Treatment Revenue by Countries

        7.1.3 Germany

        7.1.4 France

        7.1.5 UK

        7.1.6 Italy

        7.1.7 Russia

    7.2 Europe Chronic Pain Treatment by Product

    7.3 Europe Chronic Pain Treatment by End User

8 Asia Pacific

    8.1 Asia Pacific Chronic Pain Treatment by Countries

        8.1.1 Asia Pacific Chronic Pain Treatment Sales by Countries

        8.1.2 Asia Pacific Chronic Pain Treatment Revenue by Countries

        8.1.3 China

        8.1.4 Japan

        8.1.5 Korea

        8.1.6 India

        8.1.7 Australia

        8.1.8 Indonesia

        8.1.9 Malaysia

        8.1.10 Philippines

        8.1.11 Thailand

        8.1.12 Vietnam

        8.1.13 Singapore

    8.2 Asia Pacific Chronic Pain Treatment by Product

    8.3 Asia Pacific Chronic Pain Treatment by End User

9 Central & South America

    9.1 Central & South America Chronic Pain Treatment by Countries

        9.1.1 Central & South America Chronic Pain Treatment Sales by Countries

        9.1.2 Central & South America Chronic Pain Treatment Revenue by Countries

        9.1.3 Brazil

    9.2 Central & South America Chronic Pain Treatment by Product

    9.3 Central & South America Chronic Pain Treatment by End User

10 Middle East and Africa

    10.1 Middle East and Africa Chronic Pain Treatment by Countries

        10.1.1 Middle East and Africa Chronic Pain Treatment Sales by Countries

        10.1.2 Middle East and Africa Chronic Pain Treatment Revenue by Countries

        10.1.3 GCC Countries

        10.1.4 Turkey

        10.1.5 Egypt

        10.1.6 South Africa

    10.2 Middle East and Africa Chronic Pain Treatment by Product

    10.3 Middle East and Africa Chronic Pain Treatment by End User

11 Company Profiles

    11.1 Eli Lilly and Company

        11.1.1 Eli Lilly and Company Company Details

        11.1.2 Company Business Overview

        11.1.3 Eli Lilly and Company Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.1.4 Eli Lilly and Company Chronic Pain Treatment Products Offered

        11.1.5 Eli Lilly and Company Recent Development

    11.2 GlaxoSmithKline

        11.2.1 GlaxoSmithKline Company Details

        11.2.2 Company Business Overview

        11.2.3 GlaxoSmithKline Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.2.4 GlaxoSmithKline Chronic Pain Treatment Products Offered

        11.2.5 GlaxoSmithKline Recent Development

    11.3 Pfizer

        11.3.1 Pfizer Company Details

        11.3.2 Company Business Overview

        11.3.Pfizer Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.3.4 Pfizer Chronic Pain Treatment Products Offered

        11.3.5 Pfizer Recent Development

    11.4 Medtronic

        11.4.1 Medtronic Company Details

        11.4.2 Company Business Overview

        11.4.3 Medtronic Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.4.4 Medtronic Chronic Pain Treatment Products Offered

        11.4.5 Medtronic Recent Development

    11.5 Abbott Laboratories

        11.5.1 Abbott Laboratories Company Details

        11.5.2 Company Business Overview

        11.5.3 Abbott Laboratories Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.5.4 Abbott Laboratories Chronic Pain Treatment Products Offered

        11.5.5 Abbott Laboratories Recent Development

    11.6 Boston Scientific Corporation

        11.6.1 Boston Scientific Corporation Company Details

        11.6.2 Company Business Overview

        11.6.3 Boston Scientific Corporation Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.6.4 Boston Scientific Corporation Chronic Pain Treatment Products Offered

        11.6.5 Boston Scientific Corporation Recent Development

    11.7 Novartis AG

        11.7.1 Novartis AG Company Details

        11.7.2 Company Business Overview

        11.7.3 Novartis AG Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.7.4 Novartis AG Chronic Pain Treatment Products Offered

        11.7.5 Novartis AG Recent Development

    11.8 Johnson & Johnson

        11.8.1 Johnson & Johnson Company Details

        11.8.2 Company Business Overview

        11.8.3 Johnson & Johnson Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.8.4 Johnson & Johnson Chronic Pain Treatment Products Offered

        11.8.5 Johnson & Johnson Recent Development

    11.9 AstraZeneca PLC

        11.9.1 AstraZeneca PLC Company Details

        11.9.2 Company Business Overview

        11.9.3 AstraZeneca PLC Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.9.4 AstraZeneca PLC Chronic Pain Treatment Products Offered

        11.9.5 AstraZeneca PLC Recent Development

    11.10 Bristol-Myers Squibb

        11.10.1 Bristol-Myers Squibb Company Details

        11.10.2 Company Business Overview

        11.10.3 Bristol-Myers Squibb Chronic Pain Treatment Sales, Revenue and Gross Margin (2013-2018)

        11.10.4 Bristol-Myers Squibb Chronic Pain Treatment Products Offered

        11.10.5 Bristol-Myers Squibb Recent Development

    11.11 Becton, Dickinson and Company

    11.12 Sanofi

12 Future Forecast

    12.1 Chronic Pain Treatment Market Forecast by Regions

        12.1.1 Global Chronic Pain Treatment Sales Forecast by Regions 2018-2025

        12.1.2 Global Chronic Pain Treatment Revenue Forecast by Regions 2018-2025

    12.2 Chronic Pain Treatment Market Forecast by Product

        12.2.1 Global Chronic Pain Treatment Sales Forecast by Product 2018-2025

        12.2.2 Global Chronic Pain Treatment Revenue Forecast by Product 2018-2025

    12.3 Chronic Pain Treatment Market Forecast by End User

    12.4 North America Chronic Pain Treatment Forecast

    12.5 Europe Chronic Pain Treatment Forecast

    12.6 Asia Pacific Chronic Pain Treatment Forecast

    12.7 Central & South America Chronic Pain Treatment Forecast

    12.8 Middle East and Africa Chronic Pain Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    13.1 Market Opportunities and Drivers

    13.2 Market Challenges

    13.3 Market Risks/Restraints

    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

    14.1 Value Chain Analysis

    14.2 Chronic Pain Treatment Customers

    14.3 Sales Channels Analysis

        14.3.1 Sales Channels

        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

    16.1 Research Methodology

        16.1.1 Methodology/Research Approach

        16.1.2 Data Source

    16.2 Author Details

Sidebar Menu